Panax total saponin content specifications: more than 80% (HPLC) Chinese Pharmacopoeia 2010 edition of total saponins of Panax origin of this source product Araliaceae Panax Panax Notoginseng (Burk.) FHChen dried root. The main component of total saponins of Panax ginseng saponin Rg1, ginsenoside Rb1, notoginsenoside R1, ginsenoside Re, total saponins of Panax ginseng saponin Rd identification: consistent with the reference map. Loss on drying: not more than 7% Residue on ignition: not more than 0.9% of heavy metals: less than 20PPM resin residue: Complies with the requirements of the Chinese Pharmacopoeia pharmacological effects of total saponins of Panax 1, can reduce cerebral vascular resistance, increase of the internal carotid artery blood flow. 2, inhibit ADP, AA, PAF and thrombin-induced human platelet aggregation. 3, can reduce blood viscosity and inhibit thrombosis. 4, can improve microcirculation. 5, can improve cerebral ischemia, functional and behavioral disorders caused by cerebral infarction. 6, the expansion of the coronary arteries, increased coronary blood flow, anti-atherosclerosis. 1, stable quality strict quality control system, tight production critical control point system, uniform and stable product quality. 2, high levels of indicators of high purity, Rb1 and Rg1 were greater than 32%, R1 is greater than 7%; Rb1 + Rg1 + R1> 72%, more than the national standard of 20%. 3, green, no organic solvent residue-free organic solvent residues, heavy metals, pesticide residues is very low, taking the safer, more in line with the development trend of the times. 4, strict quality control to make the product more reliable needle in strict accordance with the standards of production, product quality is more stable, more secure, more in line with production requirements preparations